Zacks Research Brokers Increase Earnings Estimates for TBPH
Theravance Biopharma, Inc. (NASDAQ:TBPH – Free Report) – Investment analysts at Zacks Research lifted their Q1 2027 earnings estimates for Theravance Biopharma in a research report issued to clients and investors on Wednesday, April 23rd. Zacks Research analyst R. Department now expects that the biopharmaceutical company will post earnings per share of ($0.40) for the […]
Theravance Biopharma, Inc. (NASDAQ:TBPH – Free Report) – Investment analysts at Zacks Research lifted their Q1 2027 earnings estimates for Theravance Biopharma in a research report issued to clients and investors on Wednesday, April 23rd. Zacks Research analyst R. Department now expects that the biopharmaceutical company will post earnings per share of ($0.40) for the […]
